MLchartDataset catalogue

Tarvacin

Term · Oncology and biomedicine · MLC-T-ONC-008529

A substance being studied in the treatment of several types of cancer and infections caused by certain viruses. It binds to substances on the surface of tumor cells, certain viruses, and cells infected with a virus. The immune system detects Tarvacin on the cells and the viruses and may destroy them. It is a type of monoclonal antibody and a type of targeted therapy agent. Also called bavituximab.

Table 1. Record
IdentifierMLC-T-ONC-008529
FieldOncology and biomedicine
Synonymsbavituximab
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008529",
  "term": "Tarvacin",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of several types of cancer and infections caused by certain viruses. It binds to substances on the surface of tumor cells, certain viruses, and cells infected with a virus. The immune system detects Tarvacin on the cells and the viruses and may destroy them. It is a type of monoclonal antibody and a type of targeted therapy agent. Also called bavituximab.",
  "synonyms": [
    "bavituximab"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/tarvacin/"
}

Record 16,004 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.